We describe a case of fo llicular dendriti c cell sarcoma (FDCS) of the tonsil in a 59-year-old woman. She was successfully treated with excision of the mass and postoperative radiation therapy. According to our review of the literature, only 25 cases of extranodal FDCS in the head and neck have been previously reported, including only 10 cases that involved a tonsil. We briefly review these earlier reports, and we discuss the diagnosis and management of FDCS.
Introduction
Follicular dend ritic cells are nonlymph oid , nonph agocytic acce ssory cells of the lymphoid system. Their function is to capture and present antigens and immune compl exes to B cells.J Follicul ar dendriti c cell sarco ma (FDCS) is a rare entity, as evidenced by the small number of cases reported in the literature. Only 25 cases of extranodal FDCS in the head and neck have been published,' and only 10 of these have involved the tonsil ." !" In this articl e, we describ e the eleventh such case , and we discuss the diagno stic and treatment considerations.
Case report
A59-year-old woman presented to the otolaryngology clinic with a 2-yea r history of a right tonsil mass that had been found by a physician at another institution.The patient had a history of obstructive sleep apnea with snoring. She denied dysphagia, ody nophagia, weight loss, and otalgia.
Examination confirm ed the presence of a4-cm exophytic mass involving the right tonsil. No other masses or Iymph- The patient was brought to the operating room for endosco py and biopsy. Histopathologic analysis of the specimen identified FDCS . Hem atoxylin and eosin (H&E) stains identified spindle-and ova l-shaped cells form ing whorls with freq uent mul tinucleated giant cells (figure 2). Immun ohistochemi cal stains were positi ve for CD21, CD23, and CD35 and negative for CD Ip, S-I00, CD20, CD 3, CD31, CD34, and cytokeratin.
The mass was excised (figure 3) via wide local excision of the right tonsil with primary closure. The patient had no evidence of regional or distant metastasis. She underwent postoperative radiati on therapy, receiving 60 and 50 Gy to the oropharynx and neck, respectively. Eighte en months after the cessation of treatm ent, she exhibited no eviden ce of recur rence.
Discussion
Our analysis of the 10 previ ously reported cases of FDCS of the tonsil revealed a I: I distributi on of men and women and an age range of 18 to 77 years (mean: 45).2.10 Except for I patient who recei ved preoperative radiation , all patient s were treated primarily with tonsillectomy. Radical neck dissection was includ ed in 4 of these cases. Only I instance of cer vical metastasis was found durin g the initial workup. Postoperative radiation was performed in 3 cases, with chemotherapy added in 2 of them . Follow-up, which ranged fro m 3 month s to 8 years, yielded 2 cases of recurrence. One ca se involved a local recurrence with cervical metastasi s at 4.5 years, and the other involved metastasis to the lung.
The neoplastic process associa ted with follicular dendritic of the FDCS tumor markers ranges from 63 to 94%.14 The diagno sis of FDCS can be elucidated if the cell is immu nore active to one or more of the above-mentioned FDCS markers.
The differential diagno sis for FDCS includes ectopic meningioma, ectopic thymoma, metastatic carcinoma, malign ant melanoma , malignant fibrou s histiocytom a, and large-c ell lymph oma." These entities differ from FDCS structurally and immunohistochemically.
The beh avior of FDCS is similar to that of low-and intermediate-grade malignant neopl asms and much like that of soft-tissue sarcoma. The similar properties include an increased incidence of local recu rrence and occasion al regional and distant metastases. 12 The optimal treatment ofFDCS has not been determined bec ause of the rarity of this tumo r. Surgical excision has been the most common treatment. Postoperati ve radiation and even chemotherapy have been tried , but their survival benefit is unknown.' ?
